Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06874322 · ClinicalTrials.gov registry record · NA
Voiceitt for People With Impairments in Speech
A NA study of Speech Disorder and Speech Impairment, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06874322: Recruiting NA study of Speech Disorder and Speech Impairment, sponsored by University of Pittsburgh.
NCT06874322 is a NA study of Speech Disorder and Speech Impairment that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 20 participants, below the 322-participant average among 3 other Speech Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06874322, a NA study of Speech Disorder and Speech Impairment, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.
Primary Outcome
Change in Communication Abilities as measured by Speech Intelligibility Rating (SIR) that quantifies clarity of speech. The rating ranges from 1-5. low rating means speech is unintelligible, and highest rating means speech is intelligible to all listeners. Change in SIR is measured by administering SIR at 3 different time points, at baseline, and two times after intervention.
Conditions Studied
Interventions
- OTHER Voiceitt
Study Locations (1)
Pennsylvania
- Center for Assistive Technology - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06874322 shows while recruiting
NCT06874322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 322-participant average among 3 other Speech Disorder trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Speech Disorder appearing as the primary indexed condition, and to 1 intervention - of which Voiceitt is the first listed.
NCT06874322 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06874322 about?
NCT06874322 is a clinical study titled "Voiceitt for People With Impairments in Speech". The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's dis...
What is the current status of trial NCT06874322?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-25. Estimated completion is 2026-08.
What conditions does trial NCT06874322 study?
This clinical trial studies the following conditions: Speech Disorder, Speech Impairment.
What interventions are being tested in trial NCT06874322?
The interventions under investigation include: Voiceitt (OTHER).
Who is sponsoring clinical trial NCT06874322?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06874322 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI